Cidara Therapeutics (CDTX) News Today → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free CDTX Stock Alerts $12.68 +0.87 (+7.37%) (As of 05/2/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineQ1 2024 EPS Estimates for Cidara Therapeutics, Inc. Decreased by Analyst (NASDAQ:CDTX)americanbankingnews.com - April 29 at 1:24 AMBrokerages Set Cidara Therapeutics, Inc. (NASDAQ:CDTX) Price Target at $71.25americanbankingnews.com - April 28 at 1:10 AMCidara Therapeutics (NASDAQ:CDTX) PT Raised to $25.00americanbankingnews.com - April 27 at 5:52 AMWBB Securities Reiterates "Strong-Buy" Rating for Cidara Therapeutics (NASDAQ:CDTX)americanbankingnews.com - April 27 at 5:18 AMCidara Therapeutics, Inc. (NASDAQ:CDTX) to Post FY2025 Earnings of $12.63 Per Share, HC Wainwright Forecastsamericanbankingnews.com - April 27 at 4:28 AMCidara Therapeutics, Inc.: Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024finanznachrichten.de - April 26 at 9:25 PMCidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024finance.yahoo.com - April 26 at 8:40 AMCidara Therapeutics (NASDAQ:CDTX) Shares Gap Up Following Analyst Upgradeamericanbankingnews.com - April 26 at 1:32 AMCidara Therapeutics, Inc. (NASDAQ:CDTX) Given Average Recommendation of "Buy" by Brokeragesmarketbeat.com - April 25 at 4:58 PMCidara Therapeutics (NASDAQ:CDTX) Shares Gap Up on Analyst Upgrademarketbeat.com - April 25 at 4:48 PMWBB Securities Reaffirms "Strong-Buy" Rating for Cidara Therapeutics (NASDAQ:CDTX)marketbeat.com - April 25 at 4:40 PMCidara Therapeutics (NASDAQ:CDTX) PT Raised to $25.00 at Needham & Company LLCmarketbeat.com - April 25 at 3:30 PMCDTX LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – CDTXbusinesswire.com - April 25 at 11:25 AMCidara Therapeutics shares surge 30% after reacquiring flu treatmentmsn.com - April 24 at 11:50 PMCidara Therapeutics To Sell Candidiasis Treatment, Re-acquire Flu Assetmarketwatch.com - April 24 at 6:48 PMCidara stock rallies amid $240M private placement, drug updatemsn.com - April 24 at 6:48 PMCidara Therapeutics (NASDAQ:CDTX) Shares Up 7.1%marketbeat.com - April 24 at 6:15 PMCidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Millionglobenewswire.com - April 24 at 4:05 PMCidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipelineglobenewswire.com - April 24 at 4:01 PMmarketbeat.com - April 24 at 6:04 AMCidara Therapeutics' (CDTX) Overweight Rating Reaffirmed at Cantor Fitzgeraldamericanbankingnews.com - April 24 at 4:42 AMCidara Therapeutics, Inc.: Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Noticefinanznachrichten.de - April 23 at 9:45 PMCidara Therapeutics, Inc.: Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Resultsfinanznachrichten.de - April 23 at 11:42 AMCantor Fitzgerald Reiterates "Overweight" Rating for Cidara Therapeutics (NASDAQ:CDTX)marketbeat.com - April 23 at 9:16 AMCDTX Stock Earnings: Cidara Therapeutics Beats EPS, Beats Revenue for Q4 2023investorplace.com - April 22 at 11:06 PMWhy Cidara Therapeutics (CDTX) Stock Is Fallingmsn.com - April 22 at 6:54 PMCidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - April 22 at 5:10 PMCidara Therapeutics Announces Receipt of Nasdaq Delinquency Noticeglobenewswire.com - April 22 at 5:06 PMCidara Therapeutics Announces Reverse Stock Splitglobenewswire.com - April 22 at 8:49 AMCidara Therapeutics, Inc. (NASDAQ:CDTX) Short Interest Updatemarketbeat.com - April 15 at 6:52 PMCDTX Cidara Therapeutics, Inc.seekingalpha.com - April 14 at 11:18 PMBuy Rating Affirmed for Cidara Therapeutics Amid Promising Oncology Program Developmentsmarkets.businessinsider.com - April 8 at 7:41 PMHC Wainwright Reaffirms "Buy" Rating for Cidara Therapeutics (NASDAQ:CDTX)marketbeat.com - April 8 at 3:19 PMCidara Therapeutics reveals promising cancer therapy datainvesting.com - April 7 at 8:11 AMCidara Therapeutics Presents Promising New Data on Novel Drug-Fc Conjugate Candidates at the American Association for Cancer Research (AACR) Annual Meeting 2024globenewswire.com - April 5 at 3:00 PMCidara Therapeutics, Inc. (NASDAQ:CDTX) Sees Large Drop in Short Interestmarketbeat.com - March 30 at 3:18 PMCidara Therapeutics (CDTX) Set to Announce Quarterly Earnings on Thursdaymarketbeat.com - March 20 at 7:46 AMCidara Therapeutics, Inc. (CDTX)finance.yahoo.com - March 17 at 4:10 PMInsider Selling: Cidara Therapeutics, Inc. (NASDAQ:CDTX) CFO Sells 18,931 Shares of Stockinsidertrades.com - March 13 at 7:20 AMCidara Therapeutics, Inc. (NASDAQ:CDTX) CFO Sells $12,683.77 in Stockmarketbeat.com - March 12 at 10:43 PMCidara Therapeutics, Inc.edition.cnn.com - March 9 at 9:32 AMCidara Therapeutics to Present Preclincal Data on Multiple Novel Drug-Fc Conjugate Candidates at American Association for Cancer Research (AACR) Annual Meeting 2024finance.yahoo.com - March 6 at 11:37 PMCidara Therapeutics to Present Preclincal Data on Multiple Novel Drug-Fc Conjugate Candidates at American Association dor Cancer Research (AACR) Annual Meeting 2024globenewswire.com - March 6 at 8:00 AMSteven Cohen's Point72 Adds Cidara Therapeutics to Its Portfoliofinance.yahoo.com - February 15 at 8:07 AMCidara receives $11M milestone payment from partner Mundipharmamsn.com - February 12 at 6:49 PMCidara Therapeutics Gets $11.1M Milestone Payment for Rezzayomarketwatch.com - February 12 at 8:48 AMCidara Receives Milestone Payment From Mundipharma On European Approval Of REZZAYOmarkets.businessinsider.com - February 12 at 8:48 AMCidara Therapeutics Receives $11.14 Million Milestone Payment Following European Approval of REZZAYOfinance.yahoo.com - February 12 at 8:48 AMCidara Therapeutics Granted Nasdaq Listing Extensionmarkets.businessinsider.com - February 10 at 7:55 AMCidara Therapeutics, Inc.: Cidara Therapeutics Announces Approval of REZZAYO by the MHRA for the Treatment of Invasive Candidiasis in Adultsfinanznachrichten.de - January 30 at 9:20 AM Get Cidara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Have You Seen Elon’s New A.I. Device? (Picture Inside) (Ad)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast... This strange new device to protect us against that A.I. threat... CDTX Media Mentions By Week CDTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDTX News Sentiment▼0.490.33▲Average Medical News Sentiment CDTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDTX Articles This Week▼142▲CDTX Articles Average Week Get Cidara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Quince Therapeutics News Today Dyadic International News Today NKGen Biotech News Today SAB Biotherapeutics News Today OKYO Pharma News Today AVROBIO News Today Brainstorm Cell Therapeutics News Today LENZ Therapeutics News Today Cyclo Therapeutics News Today Protara Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDTX) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithNew Trump BombshellThe Freeport SocietyTruth about Trump you’ve never heardPorter & CompanyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cidara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
